Chris Sheldon, AstraZeneca's former VP and head of investor relations
September 1, 2022 07:00 AM EDTUpdated 08:36 AM
People
Pharma

Up­dat­ed: As­traZeneca wins last-minute in­junc­tion to tem­porar­i­ly stop for­mer ex­ec from start­ing GSK job

Max Gelman

Senior Editor

As­traZeneca has suc­cess­ful­ly sued to tem­porar­i­ly stop GSK from hir­ing one of its for­mer em­ploy­ees, the Fi­nan­cial Times was among those …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump taps Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, sur­geon gen­er­al picks

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

ADC biotech Ad­cen­do nabs $135M Se­ries B as it en­ters the clin­ic

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

For CDC, Trump picks Dave Wel­don, a for­mer con­gress­man who pushed for vac­cine in­jury claims

Sen­ate Ju­di­cia­ry Com­mit­tee ad­vances patent bill with new pro­tec­tions for phar­ma chal­lenges

A service from the Financial Times